EQRx Inc Performance
| EQRXWDelisted Stock | USD 0.19 0.01 5.00% |
The firm shows a Beta (market volatility) of -0.59, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning EQRx are expected to decrease at a much lower rate. During the bear market, EQRx is likely to outperform the market. EQRx Inc currently shows a risk of 0.0%. Please confirm EQRx Inc semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to decide if EQRx Inc will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days EQRx Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, EQRx is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 1.7 B |
EQRx |
EQRx Relative Risk vs. Return Landscape
If you would invest 19.00 in EQRx Inc on August 28, 2024 and sell it today you would earn a total of 0.00 from holding EQRx Inc or generate 0.0% return on investment over 90 days. EQRx Inc is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than EQRx, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
EQRx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EQRx's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as EQRx Inc, and traders can use it to determine the average amount a EQRx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| EQRXW |
Based on monthly moving average EQRx is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EQRx by adding EQRx to a well-diversified portfolio.
EQRx Fundamentals Growth
EQRx Stock prices reflect investors' perceptions of the future prospects and financial health of EQRx, and EQRx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EQRx Stock performance.
| EBITDA | (517.58 M) | |||
| Cash And Equivalents | 456.47 M | |||
| Cash Per Share | 10.51 X | |||
| Total Debt | 3.83 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | (8.18) X | |||
| Cash Flow From Operations | (287.27 M) | |||
| Earnings Per Share | (7.65) X | |||
| Total Asset | 1.46 B | |||
| Retained Earnings | (527.59 M) | |||
About EQRx Performance
Evaluating EQRx's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if EQRx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if EQRx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. EQRx, Inc. was founded in 2020 and is based in Cambridge, Massachusetts. Eqrx Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 216 people.Things to note about EQRx Inc performance evaluation
Checking the ongoing alerts about EQRx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for EQRx Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| EQRx Inc is not yet fully synchronised with the market data | |
| EQRx Inc has some characteristics of a very speculative penny stock | |
| EQRx Inc has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (169.09 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| EQRx Inc has accumulated about 456.47 M in cash with (287.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.51, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing EQRx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EQRx's stock is overvalued or undervalued compared to its peers.
- Examining EQRx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EQRx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of EQRx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EQRx's stock. These opinions can provide insight into EQRx's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in EQRx Stock
If you are still planning to invest in EQRx Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EQRx's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |